Organic Process Research & Development · 2018 · 18 citations · 31 references
PharmacyChemistryMedicinal ChemistryCatalysisDrug DiscoverySynthetic Medicinal ChemistryCatalyst PreparationCatalyst SynthesisCatalytic MechanismsNatural Product Drug DiscoveryArylation ReactionsCatalyst Development For SynthesisCopper-catalyzed CouplingMedicinal Chemistry ApplicationsMulti-step SynthesisSelectivitySynthetic Route OptimizationThiazole Synthesis
There is significant interest in the development of process routes for active pharmaceutical ingredients using C–H arylation methodology. An efficient and practical synthetic route for febuxostat (1), which is the first non-purine-type xanthine oxidase inhibitor, was established via palladium- and copper-catalyzed C–H arylation of thiazole with aryl bromide. The catalyst loading was reduced to 0.1 mol % for the intermolecular C–H arylation, and a three-step synthesis produced febuxostat in 89% overall yield with excellent selectivity.
31
Kenneth R. Hande, Richard M. Noone, William J. Stone · The American Journal of Medicine · 1984 · 673 citations
Anthony O. King, Nobuhisa Okukado, Ei‐ichi Negishi · Journal of the Chemical Society Chemical Communications · 1977 · 564 citations